Market Tracker

09/30 5:16pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.10
Delayed Data
As of Sep 30
 +0.17 / +2.14%
Today’s Change
5.57
Today|||52-Week Range
10.95
-24.93%
Year-to-Date

Today’s Trading

Previous close7.93
Today’s open7.98
Day’s range7.89 - 8.15
Volume1,095,631
Average volume (3 months)1,460,761
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,452.75%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratio73.6
Price/Sales20.49
Price/Book2.46

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...+0.04+0.11%
EGRXEagle Pharmaceutical...+0.03+0.04%
ARRYArray Biopharma Inc+0.51+8.17%
FOLDAmicus Therapeutics ...+0.33+4.67%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts